Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fernando C. Fervenza,Gerald B. Appel,Sean J. Barbour,Brad H. Rovin,Richard A. Lafayette,Nabeel Aslam,Jonathan Ashley Jefferson,Patrick Gipson,Dana V. Rizk,John R. Sedor,James F. Simon,Ellen T. McCarthy,Paul Brenchley,Sanjeev Sethi,Carmen Avila-Casado,Heather Beanlands,John C. Lieske,David Philibert,Tingting Li,Lesley F. Thomas,Dolly F. Green,Luis A. Juncos,Lada Beara-Lasic,Samuel S. Blumenthal,Amy Sussman,Stephen B. Erickson,Michelle Hladunewich,Pietro A. Canetta,Lee A. Hebert,Nelson Leung,Jay Radhakrishnan,Heather N. Reich,Samir Parikh,Debbie S. Gipson,Dominic K. Lee,Bruno R. da Costa,Peter Jüni,Daniel C. Cattran

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

2019

Abstract Background B-cell anomalies play a role in the pathogenesis of membranous nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for induc...

Keywords:

Pathogenesis
Medicine
Rituximab
Surgery
Gastroenterology
Membranous nephropathy
Internal medicine
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

148

Citations